Your browser does not support iframes.
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Haemonetics Corp.
(NY:
HAE
)
41.14
USD
+1.25 (+3.13%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Haemonetics Corp.
< Previous
1
2
3
4
5
6
Next >
Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical,
May 01, 2013
from
PR Newswire
Haemonetics Completes Hemerus Medical, LLC Acquisition
May 01, 2013
from
PR Newswire
Haemonetics Sets Date for Investor/Analyst Meeting
April 24, 2013
from
PR Newswire
Haemonetics Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013
April 01, 2013
from
PR Newswire
Haemonetics to Present at The Raymond James Institutional Investors Conference
February 25, 2013
from
PR Newswire
Haemonetics' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety
February 14, 2013
from
PR Newswire
Haemonetics to Present at Citi 2013 Global Healthcare Conference
February 13, 2013
from
PR Newswire
Haemonetics to Present at Leerink Swann 2013 Global Healthcare Conference
February 06, 2013
from
PR Newswire
The Reason It Trades, What's Moving NWSA, CPNO, GSK and HAE
January 31, 2013
from
Marketwired News Releases
Haemonetics Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-To-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
January 30, 2013
from
PR Newswire
Haemonetics Sets Date for Third Quarter Fiscal Year 2013 Earnings Release: January 30, 2013
January 09, 2013
from
PR Newswire
Haemonetics to Provide an Update on Key Growth Initiatives at J.P. Morgan Health Care Conference
January 04, 2013
from
PR Newswire
Haemonetics to Present at the 31st Annual J.P. Morgan Health Care Conference
December 21, 2012
from
PR Newswire
Allscripts Names Paul M. Black Chief Executive Officer
December 19, 2012
Glen Tullman Steps Down as CEO and Board Member
Read More
from
PR Newswire
Haemonetics Effects 2-For-1 Split of Its Common Stock
December 03, 2012
from
PR Newswire
Pall Corporation Reports First Quarter Results
November 28, 2012
from
Business Wire News Releases
Haemonetics Reports Second Quarter Fiscal 2013 Revenue Up 22%, Organic Revenue Up 6% and Adjusted EPS of $0.90, Reaffirms Fiscal 2013 Guidance and Announces Two-For-One Stock Split
October 29, 2012
from
PR Newswire
Haemonetics Announces Roll Out of its BloodTrack Solution to 51 Hospitals Across Ireland
October 19, 2012
Integrated inventory and transfusion management solution improves security, verification and monitoring of blood across the supply chain
Read More
from
PR Newswire
Haemonetics to Present at the Jefferies 2012 Global Healthcare Conference
October 18, 2012
from
PR Newswire
Haemonetics Showcases Entire Product Portfolio at AABB Meeting in Boston
October 04, 2012
Comprehensive, End-to-End Blood Management Solutions Help Blood Collectors and Hospitals Improve Efficiencies and Reduce Costs
Read More
from
PR Newswire
Haemonetics Sets Date for Second Quarter Fiscal Year 2013 Earnings Release: October 29, 2012
September 25, 2012
from
PR Newswire
Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
September 17, 2012
from
PR Newswire
Pall Corporation Reports Fourth Quarter and Full Year Results
September 12, 2012
from
Business Wire News Releases
Haemonetics to Present at the Morgan Stanley Global Healthcare Conference
August 30, 2012
from
PR Newswire
Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Pall's Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 201
August 01, 2012
from
PR Newswire
Haemonetics Completes Acquisition of Pall's Transfusion Medicine Business
August 01, 2012
from
PR Newswire
Ellen M. Zane Joins Haemonetics Board of Directors
July 27, 2012
from
PR Newswire
Haemonetics Sets Date for First Quarter Fiscal Year 2013 Earnings Release: August 2, 2012
July 03, 2012
from
PR Newswire
Pall Corporation Reports Third Quarter Results
June 06, 2012
from
Business Wire News Releases
Haemonetics to Present at the Jefferies 2012 Global Healthcare Conference
May 22, 2012
from
PR Newswire
< Previous
1
2
3
4
5
6
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.